BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 25962770)

  • 1. Geostatistical modeling of malaria endemicity using serological indicators of exposure collected through school surveys.
    Ashton RA; Kefyalew T; Rand A; Sime H; Assefa A; Mekasha A; Edosa W; Tesfaye G; Cano J; Teka H; Reithinger R; Pullan RL; Drakeley CJ; Brooker SJ
    Am J Trop Med Hyg; 2015 Jul; 93(1):168-177. PubMed ID: 25962770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using serological measures to monitor changes in malaria transmission in Vanuatu.
    Cook J; Reid H; Iavro J; Kuwahata M; Taleo G; Clements A; McCarthy J; Vallely A; Drakeley C
    Malar J; 2010 Jun; 9():169. PubMed ID: 20553604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-malarial seroprevalence assessment during an elimination programme in Chabahar District, south-eastern Iran.
    Zakeri S; van den Hoogen LL; Mehrizi AA; Karimi F; Raeisi A; Drakeley C
    Malar J; 2016 Jul; 15(1):382. PubMed ID: 27448606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. School-based surveys of malaria in Oromia Regional State, Ethiopia: a rapid survey method for malaria in low transmission settings.
    Ashton RA; Kefyalew T; Tesfaye G; Pullan RL; Yadeta D; Reithinger R; Kolaczinski JH; Brooker S
    Malar J; 2011 Feb; 10():25. PubMed ID: 21288368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The shape of the iceberg: quantification of submicroscopic Plasmodium falciparum and Plasmodium vivax parasitaemia and gametocytaemia in five low endemic settings in Ethiopia.
    Tadesse FG; van den Hoogen L; Lanke K; Schildkraut J; Tetteh K; Aseffa A; Mamo H; Sauerwein R; Felger I; Drakeley C; Gadissa E; Bousema T
    Malar J; 2017 Mar; 16(1):99. PubMed ID: 28253867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sparse serological evidence of Plasmodium vivax transmission in the Ouest and Sud-Est departments of Haiti.
    Weppelmann TA; von Fricken ME; Lam B; Telisma T; Existe A; Lemoine JF; Larkin J; Okech BA
    Acta Trop; 2016 Oct; 162():27-34. PubMed ID: 27230796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil.
    Soares IS; Oliveira SG; Souza JM; Rodrigues MM
    Acta Trop; 1999 Jan; 72(1):13-24. PubMed ID: 9924957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing malaria transmission in a low endemicity area of north-western Peru.
    Rosas-Aguirre A; Llanos-Cuentas A; Speybroeck N; Cook J; Contreras-Mancilla J; Soto V; Gamboa D; Pozo E; Ponce OJ; Pereira MO; Soares IS; Theisen M; D'Alessandro U; Erhart A
    Malar J; 2013 Sep; 12():339. PubMed ID: 24053144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.
    Kale S; Yadav CP; Rao PN; Shalini S; Eapen A; Srivasatava HC; Sharma SK; Pande V; Carlton JM; Singh OP; Mallick PK
    Malar J; 2019 Dec; 18(1):425. PubMed ID: 31842894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological evidence for a decline in malaria transmission following major scale-up of control efforts in a setting selected for Plasmodium vivax and Plasmodium falciparum malaria elimination in Babile district, Oromia, Ethiopia.
    Keffale M; Shumie G; Behaksra SW; Chali W; Hoogen LLVD; Hailemeskel E; Mekonnen D; Chanyalew M; Damte D; Fanta T; Ashine T; Chali S; Tetteh KKA; Birhanu DD; Balcha TT; Aseffa A; Drakeley C; Tessema TS; Adamu H; Bousema T; Gadisa E; Tadesse FG
    Trans R Soc Trop Med Hyg; 2019 Jun; 113(6):305-311. PubMed ID: 30927007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naturally acquired antibodies to merozoite surface protein (MSP)-1(19) and cumulative exposure to Plasmodium falciparum and Plasmodium vivax in remote populations of the Amazon Basin of Brazil.
    Ladeia-Andrade S; Ferreira MU; Scopel KK; Braga EM; Bastos Mda S; Wunderlich G; Coura JR
    Mem Inst Oswaldo Cruz; 2007 Dec; 102(8):943-51. PubMed ID: 18209933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.
    Wang Q; Zhao Z; Zhang X; Li X; Zhu M; Li P; Yang Z; Wang Y; Yan G; Shang H; Cao Y; Fan Q; Cui L
    PLoS One; 2016; 11(3):e0151900. PubMed ID: 26999435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sero-epidemiological evaluation of changes in Plasmodium falciparum and Plasmodium vivax transmission patterns over the rainy season in Cambodia.
    Cook J; Speybroeck N; Sochanta T; Somony H; Sokny M; Claes F; Lemmens K; Theisen M; Soares IS; D'Alessandro U; Coosemans M; Erhart A
    Malar J; 2012 Mar; 11():86. PubMed ID: 22443375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Plasmodium falciparum and Plasmodium vivax recent exposure in an area of significantly decreased transmission intensity in Central Vietnam.
    Kattenberg JH; Erhart A; Truong MH; Rovira-Vallbona E; Vu KAD; Nguyen THN; Nguyen VH; Nguyen VV; Bannister-Tyrrell M; Theisen M; Bennet A; Lover AA; Tran TD; Nguyen XX; Rosanas-Urgell A
    Malar J; 2018 Apr; 17(1):180. PubMed ID: 29703200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologically defined variations in malaria endemicity in Pará state, Brazil.
    Cunha MG; Silva ES; Sepúlveda N; Costa SP; Saboia TC; Guerreiro JF; Póvoa MM; Corran PH; Riley E; Drakeley CJ
    PLoS One; 2014; 9(11):e113357. PubMed ID: 25419900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal changes in the antibody responses against Plasmodium falciparum merozoite surface antigens in areas of differing malaria endemicity in Indonesia.
    Supargiyono S; Bretscher MT; Wijayanti MA; Sutanto I; Nugraheni D; Rozqie R; Kosasih AA; Sulistyawati S; Hawley WA; Lobo NF; Cook J; Drakeley CJ
    Malar J; 2013 Dec; 12():444. PubMed ID: 24321092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microscopic and molecular evidence of the presence of asymptomatic Plasmodium falciparum and Plasmodium vivax infections in an area with low, seasonal and unstable malaria transmission in Ethiopia.
    Golassa L; Baliraine FN; Enweji N; Erko B; Swedberg G; Aseffa A
    BMC Infect Dis; 2015 Aug; 15():310. PubMed ID: 26242405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting.
    Dewasurendra RL; Dias JN; Sepulveda N; Gunawardena GS; Chandrasekharan N; Drakeley C; Karunaweera ND
    BMC Infect Dis; 2017 Jan; 17(1):49. PubMed ID: 28068925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria serology data from the Guiana shield: first insight in IgG antibody responses to Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae antigens in Suriname.
    Labadie-Bracho MY; van Genderen FT; Adhin MR
    Malar J; 2020 Oct; 19(1):360. PubMed ID: 33032606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographical patterns of malaria transmission based on serological markers for falciparum and vivax malaria in Ratanakiri, Cambodia.
    Kerkhof K; Sluydts V; Heng S; Kim S; Pareyn M; Willen L; Canier L; Sovannaroth S; Ménard D; Sochantha T; Coosemans M; Durnez L
    Malar J; 2016 Oct; 15(1):510. PubMed ID: 27756395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.